Skip to main content
Clinical Trials/CTRI/2017/06/008841
CTRI/2017/06/008841
Completed
N/A

Role of neuromuscular monitoring for the judicious use of Neuromuscular blockers and the reversal agents.

RESEARCH CE0 sites200 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: null- patients posted for general surgical proceudres of less than 2 hours duration under general anaeshtesia.
Sponsor
RESEARCH CE
Enrollment
200
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
RESEARCH CE

Eligibility Criteria

Inclusion Criteria

  • The primary outcome of the study was the time required to achieve TOF ratio of 0\.9 at the end of surgery, without giving neostigmine while extubating the patients at TOF ratio of 0\.9\.

Exclusion Criteria

  • 1\) The patients with history of diabetes, myasthenia gravis.
  • 2\) The patients with hepato\-renal impairment.
  • 3\) Patients having surgery at the site where electrodes were to be applied
  • 4\) All types of emergency surgeries.

Outcomes

Primary Outcomes

Not specified

Similar Trials